Peritoneal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinNeoplasmsCyclophosphamideDoxorubicinTreatment OutcomePancreatic NeoplasmsLung NeoplasmsNeoplasm StagingBreast NeoplasmsNeoadjuvant TherapyDisease-Free SurvivalPrognosisEtoposideSurvival AnalysisSurvival RateNeoplasm Recurrence, LocalOvarian NeoplasmsDrug Administration ScheduleMethotrexateNeoplasms, Cystic, Mucinous, and SerousTesticular NeoplasmsCarboplatinPaclitaxelLiver NeoplasmsVinblastineInduction ChemotherapyNeoplasms, Second PrimaryNeoplasm MetastasisSkin NeoplasmsDrug Resistance, NeoplasmNeoplasms, Multiple PrimaryTaxoidsColorectal NeoplasmsAdenocarcinomaBone NeoplasmsIfosfamideNeoplasms, Germ Cell and EmbryonalBleomycinFollow-Up StudiesAntimetabolites, AntineoplasticTumor Markers, BiologicalDeoxycytidineOrganoplatinum CompoundsKidney NeoplasmsLymphomaLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingAnthracyclinesStomach NeoplasmsHodgkin DiseaseChemotherapy, Cancer, Regional PerfusionCytarabineImmunohistochemistryAdenocarcinoma, MucinousCarcinoma, Non-Small-Cell LungSalvage TherapyTime FactorsCarcinomaNeoplasms, Glandular and EpithelialRadiotherapySoft Tissue NeoplasmsDNA, NeoplasmRadiotherapy, AdjuvantNeutropeniaColonic NeoplasmsTransplantation, AutologousVomitingAntineoplastic Agents, PhytogenicNauseaGastrointestinal NeoplasmsThyroid NeoplasmsMediastinal NeoplasmsProspective StudiesAntibiotics, AntineoplasticMyeloproliferative DisordersClinical Trials as TopicOsteosarcomaDacarbazineKaplan-Meier EstimateAppendiceal NeoplasmsNeoplasm ProteinsCarcinoma, Squamous CellCarmustineNeoplasms, ExperimentalSarcomaHead and Neck NeoplasmsLymphatic MetastasisHematologic NeoplasmsNeoplasm InvasivenessEye NeoplasmsLomustineCell Line, TumorTomography, X-Ray ComputedUterine NeoplasmsGranulocyte Colony-Stimulating Factor